Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein
about
Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodiesEBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcriptionAntiviral action of the tumor suppressor ARFGene expression patterns in dendritic cells infected with measles virus compared with other pathogens.Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expressionTrim5alpha protein restricts both HIV-1 and murine leukemia virusEbola virus infection inversely correlates with the overall expression levels of promyelocytic leukaemia (PML) protein in cultured cellsResistance to Rhabdoviridae Infection and Subversion of Antiviral ResponsesVesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerThe potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1Origin and diversification of TRIM ubiquitin ligases.Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodiesImplication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.Nuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected a549 cells identified by high-resolution two-dimensional gel electrophoresisA role for cytoplasmic PML in cellular resistance to viral infectionA large new subset of TRIM genes highly diversified by duplication and positive selection in teleost fish.A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics.Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon.The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription.Sendai virus C proteins counteract the interferon-mediated induction of an antiviral stateRole of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus.Interactions of herpes simplex virus type 1 with ND10 and recruitment of PML to replication compartments.Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA.GRIM-19 Expression and Function in Human Gliomas.Cytokine-induced tumor suppressors: a GRIM storyIdentification of RING finger protein 4 (RNF4) as a modulator of DNA demethylation through a functional genomics screenSUMOylation promotes PML degradation during encephalomyocarditis virus infection.Effects of promyelocytic leukemia protein on virus-host balance.Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteinsPostinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell linesGRIM-19: A Double-edged Sword that Regulates Anti-Tumor and Innate Immune Responses.Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradationFas-associated death domain (FADD) and the E3 ubiquitin-protein ligase TRIM21 interact to negatively regulate virus-induced interferon productionDetermination of minimum herpes simplex virus type 1 components necessary to localize transcriptionally active DNA to ND10.Vicious circle: systemic autoreactivity in Ro52/TRIM21-deficient micePromyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effectsCross talk between PML and p53 during poliovirus infection: implications for antiviral defense.SIRT1 stabilizes PML promoting its sumoylationImplication of PMLIV in both intrinsic and innate immunity.Influence of ND10 components on epigenetic determinants of early KSHV latency establishment.
P2860
Q24293202-E48E2F2A-D5C9-41CF-87B8-BF67C0F2C30DQ24298061-7037D54A-32F3-47BE-85C2-099A67CD1258Q24301787-7E510407-88AD-4D01-9AB5-1CD6F0395F8DQ24541511-2F51E0EE-3755-4F80-B23A-B871B3FF39EDQ24543400-36AAC0BA-57FC-45A3-83F4-CB935A2BD2C9Q24561922-C4622BFF-497E-47FF-B558-95DD127B658FQ24794365-8F7CB981-B868-41E0-95A3-BBBDBDFE4E7BQ26801290-245C5DA4-2322-472C-BBB7-58FF3FF03423Q27021839-3054662C-5AF7-4477-816C-A009D544779EQ27027918-5A3AD955-D0A1-4202-BA2B-DCAB0AFF024BQ30424095-751CFAFA-6514-4F89-968F-84CD1D5984D9Q30845046-1D7E4BFC-3446-4F7F-99B4-2A8DF70D2FA6Q30860339-29C30540-D1E5-4C17-9CA1-2A9F146AAE3BQ31120475-204DF1DB-B80D-4DFC-897F-1698EBD0B5E5Q33338503-CA4E3D6A-72F0-415A-93F7-DC9A5072AA4EQ33406010-C8C896F0-4066-4B01-9DD1-5CF8EAB4F6AFQ33596988-20B6FF5B-C466-407B-AE76-DBEC45D438AFQ33652663-5000328D-1A5E-4EAB-A2AC-2246631A329FQ33724291-8ED4B042-C8BD-4266-8506-2D0A414F49A6Q33817139-4980B696-7A1B-4F8A-81E7-AEB40C32BFEFQ33842651-8E3B1371-E150-41B1-81B5-EE27E345C655Q33850767-054A5FAC-C1FA-48F8-800F-CA5BD59DB8CDQ33853034-EFA4EEF1-5616-4002-83E5-F1A1174B48DCQ34044498-37641D8E-0B1D-460E-9C04-49E03D716B92Q34077445-217AA425-8A01-4F01-933B-CB8C8CC37015Q34093782-FAAB3635-B501-4A07-B59A-44611E6CD5FBQ34295991-6F6AD8DF-C429-4470-B86F-9A570C08F782Q34335521-E9E7C55A-AA9B-482B-B79A-396B48B09FD5Q34345244-B16A6955-0C5A-41CC-9260-669B8D64F2AFQ34436727-A8CAF759-9155-46C4-87A1-34488BAFAB0FQ34497752-24C30D5B-CCBC-4051-95BD-0A935FA0CD86Q34638627-4C4E44F8-1D51-43BB-9FA7-BAF3AB7C7A01Q34675854-1B5082F5-BE6D-48E6-A377-E820BB2B63ECQ34976574-A82846A5-3A1D-491B-B8BC-C7352E473719Q34994387-80FF1261-2DB0-4319-A887-D766454010CEQ35020024-104B423C-4F6E-4FD4-B958-B3DF9AEE4880Q35024144-F5C57EC0-F8C0-4497-AD6F-4545BBFDB054Q35092583-5D90BF5C-B98E-4A02-BA5C-FD8A599DFA88Q35105677-C776ECA3-1CF1-4951-AF27-CB34CDD8B511Q35208258-14789AB6-D239-442D-8400-B638747B182C
P2860
Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Resistance to virus infection ...... promyelocytic leukemia protein
@ast
Resistance to virus infection ...... promyelocytic leukemia protein
@en
Resistance to virus infection ...... promyelocytic leukemia protein
@en-gb
Resistance to virus infection ...... promyelocytic leukemia protein
@nl
type
label
Resistance to virus infection ...... promyelocytic leukemia protein
@ast
Resistance to virus infection ...... promyelocytic leukemia protein
@en
Resistance to virus infection ...... promyelocytic leukemia protein
@en-gb
Resistance to virus infection ...... promyelocytic leukemia protein
@nl
prefLabel
Resistance to virus infection ...... promyelocytic leukemia protein
@ast
Resistance to virus infection ...... promyelocytic leukemia protein
@en
Resistance to virus infection ...... promyelocytic leukemia protein
@en-gb
Resistance to virus infection ...... promyelocytic leukemia protein
@nl
P2093
P2860
P3181
P1433
P1476
Resistance to virus infection ...... promyelocytic leukemia protein
@en
P2093
L Pelicano
M K Chelbi-Alix
P2860
P304
P3181
P407
P577
1998-02-01T00:00:00Z